Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

BTIG analyst Jake Fuller upgraded Instacart (CART) to Buy from Neutral with a $58 price target The immediate catalyst for the upgrade is a ...

DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company's ...

BTIG analyst Mark Massaro maintained a Buy rating on Castle Biosciences (CSTL – Research Report) today and set a price target of $40.00. The ...

In recent trading, P3 Health Partners Inc (PIII) stock price has shown some volatility, fluctuating -13.35% over the last five trades a ...

Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.

Brookstone Capital Management grew its holdings in shares of MicroStrategy Incorporated (NASDAQ:MSTR – Free Report) by 32.6% ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

On Monday, IREN Ltd (IREN) stock saw a decline, ending the day at $10.46 which represents a decrease of $-0.54 or -4.91% from the prior close of $11. The stock opened at $10.32 and touched a low of $9 ...

On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy rating and a price target of $6.00. The firm sees potential in the company's lead product, ANKTIVA, an IL-15 receptor ...